Company Filing History:
Years Active: 1997
Title: Michael Reedijk: Innovator in SH2-Phosphorylated Ligand Regulatory Systems
Introduction
Michael Reedijk is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biochemistry, particularly in the area of SH2-phosphorylated ligand regulatory systems. His innovative work has led to the development of a unique method for assaying substances that affect these systems.
Latest Patents
Michael Reedijk holds 1 patent for his invention titled "Method for assaying for a substance that affects an SH2 phosphorylated ligand regulatory system." This method employs an SH2-like domain or a subdomain and a phosphorylated ligand to detect the presence of substances that may influence the regulatory system. The process involves incubating the SH2-like domain and phosphorylated ligand with a suspected substance under conditions that allow for the formation of an SH2-phosphorylated ligand complex. The invention also includes methods for screening and regulating interactions involving these complexes.
Career Highlights
Michael Reedijk is affiliated with Mount Sinai Hospital Corporation, where he continues to advance research in his field. His work has implications for understanding signaling pathways and developing pharmaceutical compositions that can act as agonists or antagonists in these systems.
Collaborations
Michael has collaborated with notable figures in his field, including Anthony J Pawson, enhancing the impact of his research through shared expertise and insights.
Conclusion
Michael Reedijk's contributions to the field of biochemistry through his innovative patent demonstrate his commitment to advancing scientific knowledge and improving therapeutic approaches. His work continues to influence the understanding of SH2-phosphorylated ligand regulatory systems.